Cyclo Therapeutics- Warrants (14/11/2025) Profit Margin

Cyclo Therapeutics- Warrants (14/11/2025)'s profit margin stands at -2848.16% as of September 2024. That compares with -2019.93% in the prior-year period — down 41.0% year over year. That is below the Healthcare sector average of 13.89%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Cyclo Therapeutics- Warrants (14/11/2025) reported -2848.16% in profit margin versus -2019.93% a year earlier — a 41.0% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Cyclo Therapeutics- Warrants (14/11/2025) sits lower the Healthcare benchmark (13.89%) with a profit margin of -2848.16%. That is roughly 20600.6% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -2848.16% for Cyclo Therapeutics- Warrants (14/11/2025) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Cyclo Therapeutics- Warrants (14/11/2025)'s profit margin evolved across reporting periods, while the comparison chart places CYTHW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.